from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2608/PPE42

LFCtreatmentdescriptionclass of inhibitor

-0.739

Amikacinug/mL Amikacintranslation

0.611

Cap5-10ug/mL Capreomycintranslation

0.541

Rox10-50 ug/mL Roxithromycintranslation

-0.151

SM2-5 ug/mL Streptomycintranslation

0.097

Tet5-10 ug/mL Tetracyclinetranslation

1.134

Rif0.2-5ug/mL Rifampicintranscription

0.727

Rifp0.1-0.5ug/mL Rifapentinetranscription

4.042

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.931

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.149

CPZ10-50 ug/mL Chlorpromazinerespiration

0.609

Clofazimine10-13 ug/mL Clofaziminerespiration

0.599

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.106

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.045

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.091

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.238

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.109

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.195

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.235

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.041

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.835

KCN5-20 ug/mL Potassium cyaniderespiration

1.366

NaN30.2-2 mM Sodium aziderespiration

0.523

Nigericin50 uM Nigericinrespiration

-0.278

TRC10-150 ug/mL Triclosanrespiration

-0.615

TRZ10-25 ug/mL Thioridazinerespiration

-1.115

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.302

menadione6-10 ug/mL Menadionerespiration

0.174

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.328

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.148

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.474

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.451

NRP_1Non-replicating persistence stage 1dosRassociated

0.270

Amp0.2mg/mL AmpicillincellWall

0.017

Cephalexin20-100 ug/mL CephalexincellWall

-0.169

Cerulenin0.32-5 ug/mL CerulenincellWall

0.125

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.211

EMB10-20 ug/mL EthambutolcellWall

-0.370

Eta12-40 ug/mL EthionamidecellWall

-1.324

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.181

TLM0.1-0.2 mg/mL ThiolactomycincellWall

2.117

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.976

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.353

BZA0.12 mg/mL BenzamidearomaticAmides

0.283

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.176

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.294

H2O24 mM hydrogen peroxideDNAdamaging

-0.080

Levo10 ug/mL LevofloxacinDNAdamaging

-0.161

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.087

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.088

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.499

UVUV-irradiationDNAdamaging

0.025

ARP41-4 ug/mL Antitubercular compound ARP4?

0.345

Antimycin12.5-50 ug/mL Antimycin A?

1.034

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.091

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.494

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.756

PA8240.2-2 ug/mL PA-824?

-0.710

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.807

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.791

Verapamil50 uM Verapamil?

0.278

mercaptoethanol2 mM 2-Mercaptoethanol?

0.779

methoxatin10-20 ug/mL Methoxatin?